DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 46 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,486,383 | +42.7% | 447,138 | +38.8% | 0.00% | +100.0% |
| Q2 2023 | $3,845,731 | +41.9% | 322,088 | +58.9% | 0.00% | 0.0% |
| Q1 2023 | $2,709,658 | -38.2% | 202,667 | -0.6% | 0.00% | 0.0% |
| Q4 2022 | $4,388,036 | +10.1% | 203,905 | +2.5% | 0.00% | 0.0% |
| Q3 2022 | $3,986,000 | +45.5% | 198,952 | +30.0% | 0.00% | 0.0% |
| Q2 2022 | $2,740,000 | +165.2% | 153,043 | +47.1% | 0.00% | – |
| Q1 2022 | $1,033,000 | -19.5% | 104,034 | +36.6% | 0.00% | – |
| Q4 2021 | $1,284,000 | -28.1% | 76,168 | +1.3% | 0.00% | -100.0% |
| Q3 2021 | $1,786,000 | – | 75,226 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |